Abstract
Cell-penetrating peptides (CPPs) are promising tools for intracellular delivery. However, no consensus regarding their internalization mechanism has been reached within the scientific community. Although endocytosis seems to be the preferred internalization mechanism for most CPP-cargo complexes, examples of direct translocation have also been identified. In this review we go through the several ways of studying CPP-mediated cargo delivery in cells and the possible factors affecting the internalization pathways followed by these complexes. In addition, we analyze the CPP-mediated delivery of two relevant cargoes, namely quantum dots and nucleic acids, focusing on the internalization mechanism that they follow.
Keywords: Cell penetrating peptides, internalization mechanism, drug delivery, Quantum dot delivery and nucleic acid delivery
Current Pharmaceutical Design
Title:Intracellular Fate of Peptide-Mediated Delivered Cargoes
Volume: 19 Issue: 16
Author(s): Irene Martin, Meritxell Teixido and Ernest Giralt
Affiliation:
Keywords: Cell penetrating peptides, internalization mechanism, drug delivery, Quantum dot delivery and nucleic acid delivery
Abstract: Cell-penetrating peptides (CPPs) are promising tools for intracellular delivery. However, no consensus regarding their internalization mechanism has been reached within the scientific community. Although endocytosis seems to be the preferred internalization mechanism for most CPP-cargo complexes, examples of direct translocation have also been identified. In this review we go through the several ways of studying CPP-mediated cargo delivery in cells and the possible factors affecting the internalization pathways followed by these complexes. In addition, we analyze the CPP-mediated delivery of two relevant cargoes, namely quantum dots and nucleic acids, focusing on the internalization mechanism that they follow.
Export Options
About this article
Cite this article as:
Martin Irene, Teixido Meritxell and Giralt Ernest, Intracellular Fate of Peptide-Mediated Delivered Cargoes, Current Pharmaceutical Design 2013; 19 (16) . https://dx.doi.org/10.2174/1381612811319160007
DOI https://dx.doi.org/10.2174/1381612811319160007 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
What We Learnt from Randomized Clinical Trials and Cohort Studies of Antioxidant Vitamin? : Focus on Vitamin E and Cardiovascular Disease
Current Pharmaceutical Biotechnology Stem Cells in Stroke Repair: Current Success & Future Prospects
CNS & Neurological Disorders - Drug Targets Phytoconstituents of <i>Lantana camara</i> L.: Rekindling Hope in the Cancer Treatment
Current Bioactive Compounds Fetal Protein Restriction, Taurine and Islet Plasticity
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Novel Herbal Topical Patch Containing Curcumin and Arnica montana for the Treatment of Osteoarthritis
Current Rheumatology Reviews Molecular Mechanisms Underlying Psychological Stress and Cancer
Current Pharmaceutical Design PPAR- γ Agonist in Treatment of Diabetes: Cardiovascular Safety Considerations
Cardiovascular & Hematological Agents in Medicinal Chemistry Medication Adherence and Associated Factors among Chronic Heart Failure Clients on Follow Up Oromia Region, West Ethiopia
Cardiovascular & Hematological Agents in Medicinal Chemistry Study of drug-drug combinations based on molecular descriptors and physicochemical properties
Combinatorial Chemistry & High Throughput Screening Malignant Mesothelioma: Biology, Diagnosis and Therapeutic Approaches
Current Molecular Pharmacology Potential Anti-cancer Drugs Commonly Used for Other Indications
Current Cancer Drug Targets Cerebral White Matter Lesions, Risk of Stroke and Cerebrovascular Protection with Angiotensin Receptor Blockers
Current Drug Therapy Osmoadaptation of Mammalian Cells - An Orchestrated Network of Protective Genes
Current Genomics Energy Remodeling, Mitochondrial Disorder and Heart Failure
Current Pharmaceutical Design Therapeutical Potential of CB<sub>2</sub> Receptors in Immune-Related Diseases
Current Molecular Pharmacology Endothelin-1 Actions on Vascular Smooth Muscle Cell Functions As a Target for the Prevention of Atherosclerosis
Current Vascular Pharmacology Optimization of Important Early ADME(T) Parameters of NADPH Oxidase-4 Inhibitor Molecules
Medicinal Chemistry Cardiac Biomarkers in Acute Coronary Syndromes: A Review
Current Vascular Pharmacology Transient Left Ventricular Acute Failure after Cocaine Use
Current Drug Research Reviews A Review of the Pharmacological Properties of 3,4-dihydro-2(1H)- quinolinones
Mini-Reviews in Medicinal Chemistry